In clinical laboratory characteristics, D-dimer, CEA, CA125, CA15-3, WBC, NEUT, NLR, Fbg and α2-AP levels played critical roles in the differential diagnosis of patients with BC recurrence and no recurrence (Supplementary Table 1). This evidence concerns the gene SERPINF2 and breast cancer.